Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bon Natural Life Limited stock logo
BON
Bon Natural Life
$1.42
-0.1%
$1.38
$1.14
$73.75
$236K-0.471.72 million shs74,283 shs
NEPTF
Neptune Wellness Solutions
$0.03
+99.3%
$0.02
$0.00
$0.12
$136K-2.627,709 shs50,196 shs
Omega Therapeutics, Inc. stock logo
OMGAQ
Omega Therapeutics
$0.00
$0.05
$0.00
$1.69
$166K0.57215,590 shsN/A
Trevena, Inc. stock logo
TRVN
Trevena
$0.25
+20,733.3%
$0.70
$0.00
$7.85
$240K0.412,160 shs6,905 shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bon Natural Life Limited stock logo
BON
Bon Natural Life
+1.44%+2.17%+2.92%-10.76%-96.93%
NEPTF
Neptune Wellness Solutions
+99.33%+99.33%+113.57%+498.00%+2,989,900.00%
Omega Therapeutics, Inc. stock logo
OMGAQ
Omega Therapeutics
0.00%0.00%-84.62%-97.60%-99.79%
Trevena, Inc. stock logo
TRVN
Trevena
-99.56%-99.56%-99.87%-99.90%-99.97%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bon Natural Life Limited stock logo
BON
Bon Natural Life
N/AN/AN/AN/AN/AN/AN/AN/A
NEPTF
Neptune Wellness Solutions
0.0059 of 5 stars
0.01.00.00.00.00.00.0
Omega Therapeutics, Inc. stock logo
OMGAQ
Omega Therapeutics
2.4171 of 5 stars
3.34.00.00.00.01.71.3
Trevena, Inc. stock logo
TRVN
Trevena
1.2598 of 5 stars
3.02.00.00.00.00.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bon Natural Life Limited stock logo
BON
Bon Natural Life
0.00
N/AN/AN/A
NEPTF
Neptune Wellness Solutions
2.00
HoldN/AN/A
Omega Therapeutics, Inc. stock logo
OMGAQ
Omega Therapeutics
2.50
Moderate Buy$4.00133,233.33% Upside
Trevena, Inc. stock logo
TRVN
Trevena
2.00
Hold$5.001,900.00% Upside

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bon Natural Life Limited stock logo
BON
Bon Natural Life
$23.84M0.01$1.81 per share0.78$37.78 per share0.04
NEPTF
Neptune Wellness Solutions
$52.62M0.00N/AN/A($91.90) per share0.00
Omega Therapeutics, Inc. stock logo
OMGAQ
Omega Therapeutics
$3.09M0.05N/AN/A$1.05 per share0.00
Trevena, Inc. stock logo
TRVN
Trevena
$443K0.54N/AN/A($11.07) per share-0.02
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bon Natural Life Limited stock logo
BON
Bon Natural Life
$400KN/A0.00N/AN/AN/AN/AN/A
NEPTF
Neptune Wellness Solutions
-$60.46M-$106.72N/AN/AN/AN/AN/AN/A
Omega Therapeutics, Inc. stock logo
OMGAQ
Omega Therapeutics
-$97.43M-$1.33N/AN/AN/AN/AN/AN/AN/A
Trevena, Inc. stock logo
TRVN
Trevena
-$40.29M-$47.04N/AN/AN/AN/AN/A-119.55%11/5/2025 (Estimated)
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bon Natural Life Limited stock logo
BON
Bon Natural Life
N/AN/AN/AN/AN/A
NEPTF
Neptune Wellness Solutions
N/AN/AN/AN/AN/A
Omega Therapeutics, Inc. stock logo
OMGAQ
Omega Therapeutics
N/AN/AN/AN/AN/A
Trevena, Inc. stock logo
TRVN
Trevena
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bon Natural Life Limited stock logo
BON
Bon Natural Life
0.02
2.42
2.32
NEPTF
Neptune Wellness Solutions
N/AN/AN/A
Omega Therapeutics, Inc. stock logo
OMGAQ
Omega Therapeutics
N/AN/AN/A
Trevena, Inc. stock logo
TRVN
Trevena
N/A
2.42
2.42

Institutional Ownership

CompanyInstitutional Ownership
Bon Natural Life Limited stock logo
BON
Bon Natural Life
0.57%
NEPTF
Neptune Wellness Solutions
11.72%
Omega Therapeutics, Inc. stock logo
OMGAQ
Omega Therapeutics
97.47%
Trevena, Inc. stock logo
TRVN
Trevena
13.56%

Insider Ownership

CompanyInsider Ownership
Bon Natural Life Limited stock logo
BON
Bon Natural Life
26.48%
NEPTF
Neptune Wellness Solutions
5.10%
Omega Therapeutics, Inc. stock logo
OMGAQ
Omega Therapeutics
8.50%
Trevena, Inc. stock logo
TRVN
Trevena
2.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bon Natural Life Limited stock logo
BON
Bon Natural Life
100167,000863,000Not Optionable
NEPTF
Neptune Wellness Solutions
1304.53 million4.30 millionN/A
Omega Therapeutics, Inc. stock logo
OMGAQ
Omega Therapeutics
12055.37 million50.66 millionOptionable
Trevena, Inc. stock logo
TRVN
Trevena
40959,000841,000Optionable

Recent News About These Companies

Trevena, Inc. (TRVN) - Yahoo Finance
JMP Securities downgrades Trevena (TRVN) to a Hold
Lyme Regis town councillor John Trevena stand down
Trevena appoints new financial chief
Trevena Appoints Katrine Sutton as New CFO
HC Wainwright & Co. Downgrades Trevena (TRVN)
Why Trevena (TRVN) Stock Is Down 43% Today
Trevena, Inc. Faces Delisting from Nasdaq
Trevena Announces Receipt of Nasdaq Delisting Notification
Learn to Evaluate (TRVN) using the Charts

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Bon Natural Life stock logo

Bon Natural Life NYSE:BON

$1.42 0.00 (-0.11%)
Closing price 03:58 PM Eastern
Extended Trading
$1.42 0.00 (0.00%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally. It offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. Its products are used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company was founded in 2006 and is based in Xi'an, the People's Republic of China.

Neptune Wellness Solutions OTC:NEPTF

$0.03 +0.01 (+99.33%)
As of 08/28/2025 03:25 PM Eastern

Neptune Wellness Solutions Inc. operates as an integrated health and wellness company. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga Neutraceuticals, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, and NurturMe brands. The company offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, such as legal cannabis and hemp, nutraceuticals, and white label consumer packaged goods. It is also involved in the extraction, purification, formulation, and manufacturing of health and wellness products, such as omega-3 and hemp-derived products under various delivery forms, such as soft gels, liquids, capsules, vape pens, sprays, topicals, sachets, tinctures, concentrates, edibles, and beverages, as well as hand sanitizers, non-contact thermometers, and gloves. In addition, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada.

Omega Therapeutics stock logo

Omega Therapeutics OTCMKTS:OMGAQ

$0.0030 0.00 (0.00%)
As of 08/11/2025

Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. It also develops OTX-2002 for hepatocellular carcinoma; OTX-2101 for non-small cell lung cancer; omega epigenomic controllers (OEC) for inflammatory lung diseases, such as neutrophilic asthma, acute respiratory distress syndrome, dermatological, oncology, and rheumatological indications; OEC candidates for idiopathic pulmonary fibrosis; liver regeneration medicines; and OEC candidates for patients with diabetes and other conditions to treat corneal epithelial injury. In addition, the company develops OEC candidates for the treatment of alopecia, a disorder characterized by patches of non-scarring hair loss affecting the scalp and body. Omega Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Trevena stock logo

Trevena NASDAQ:TRVN

$0.25 +0.25 (+20,733.33%)
As of 02:24 PM Eastern

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV250, a G protein biased delta-opioid receptor agonist for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is based in Chesterbrook, Pennsylvania.